Clinical Trial: A Clinical Trial to Evaluate the Efficacy and Safety of HRS-9821 Inhalation Suspension in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07640451) titled 'A Clinical Trial to Evaluate the Efficacy and Safety of HRS-9821 Inhalation Suspension in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease' on June 01.

Brief Summary: The study is being conducted to evaluate the efficacy and safety of HRS-9821 for patients with COPD, and to explore the reasonable dosage of HRS-9821 for patients with COPD.

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: COPD

Intervention: DRUG: HRS-9821 Inhalation Suspension

HRS-9821 Inhalation Suspension.

DRUG: HRS-9821 Placebo Inhalation Suspension

HRS-9821 Placebo Inhalation Suspension.

Recruitment Status: NOT_YET...